X-120159230-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000371388.5(RHOXF2):c.295G>A(p.Gly99Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000191 in 1,206,188 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000371388.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHOXF2 | NM_032498.3 | c.295G>A | p.Gly99Ser | missense_variant | 2/4 | ENST00000371388.5 | NP_115887.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHOXF2 | ENST00000371388.5 | c.295G>A | p.Gly99Ser | missense_variant | 2/4 | 1 | NM_032498.3 | ENSP00000360441.3 |
Frequencies
GnomAD3 genomes AF: 0.0000720 AC: 8AN: 111183Hom.: 0 Cov.: 19 AF XY: 0.0000297 AC XY: 1AN XY: 33627
GnomAD3 exomes AF: 0.0000445 AC: 8AN: 179898Hom.: 0 AF XY: 0.0000454 AC XY: 3AN XY: 66008
GnomAD4 exome AF: 0.0000137 AC: 15AN: 1094962Hom.: 0 Cov.: 31 AF XY: 0.00000832 AC XY: 3AN XY: 360570
GnomAD4 genome AF: 0.0000719 AC: 8AN: 111226Hom.: 0 Cov.: 19 AF XY: 0.0000297 AC XY: 1AN XY: 33680
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2022 | The c.295G>A (p.G99S) alteration is located in exon 2 (coding exon 2) of the RHOXF2 gene. This alteration results from a G to A substitution at nucleotide position 295, causing the glycine (G) at amino acid position 99 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | RHOXF2: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at